All In MedTech

Device Trial Radar · NCT04728087

ACCEL Absorbable Hemostat

ACCEL® Absorbable Hemostat Powder Clinical Trial

Last checked: Nov 19, 2026Latest source record: Jul 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 216 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

216

Planned (sponsor's estimate)

Start

Oct 26, 2021

Primary completion

Nov 30, 2024

Study completion Jan 30, 2025

Sponsor

Lead sponsor
Hemostasis, LLCNot on our public-company list
Sponsor type
Industry
First posted
Jan 28, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ACCEL® Absorbable Hemostat Powder Clinical IDE Trial is designed as a prospective, multi-center, randomized, non-inferiority, controlled pivotal clinical trial to evaluate the safety and efficacy of the ACCEL® Absorbable Hemostat Powder as compared to gelatin sponge, for achieving hemostasis in subjects undergoing cardiovascular, liver, or soft tissue surgery, when control of oozing to moderate bleeding by standard surgical techniques is ineffective and/or impractical.

Conditions

  • Hemostasis

Interventions

  • ACCEL® Absorbable Hemostat PowderDevice

    Up to 2 bellows (10 grams nominal) of ACCEL®

  • Gelfoam® (Absorbable Gelatin Sponge, Pfizer Manufacturer Part Number 0342-01)Device

    Up to 12.5 cm x 8.0 cm of Gelfoam® or SURGIFOAM® .

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Demonstration of non-inferiorityTime frame: Day 0 / Surgery
  2. Determination of incidence of SADE and ADETime frame: Through the six (6) week follow-up.

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Keck Medical Center of USC

    Los Angeles, California · Completed

  • Saint Luke's Hospital of Kansas City

    Kansas City, Missouri · Completed

  • Washington University in St. Louis

    St Louis, Missouri · Recruiting

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.